How is myalgic encephalomyelitis and chronic fatigue syndrome managed?
Management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) focuses on symptom relief and pacing strategies, as there are currently no treatments or US Food and Drug Administration-approved medications that address the root cause of the illness. Patients experience profound fatigue, sleep problems, and post-exertional malaise, making activity regulation essential to prevent symptom crashes. Prognosis is generally poor with recovery being rare, and clinical management relies heavily on off-label medications or supportive counseling.
What we know
- Management of ME/CFS focuses on symptom management and activity regulation because there are no available treatments addressing the root cause. [2]
- Pacing is the most common management strategy used to help patients avoid triggering post-exertional malaise. [2, 3]
- There are no FDA-approved medications for ME/CFS, though certain drugs are used off-label or evaluated in experimental studies. [2]
- Recovery from ME/CFS is considered rare, and full recovery is uncommon. [2, 3]
Still open
- The underlying cause of ME/CFS remains unknown, complicating treatment approaches.
Where to go next
- how it workedWhat is post-exertional malaise?
- compared withHow does long COVID relate to ME/CFS?
- how we knowWhat are the common symptoms of ME/CFS?
- the bigger pictureHow is idiopathic chronic fatigue different from ME/CFS?
- what followedWhat controversies exist around ME/CFS care?
- an unexpected connectionCould chronic fatigue symptoms be mistaken for chronic Lyme disease?Symptoms attributed to chronic Lyme disease are often actually due to conditions like fibromyalgia or myalgic encephalomyelitis rather than a persistent infection.
Sources
- [1]Chronic fatigue syndrome treatment (Wikidata Q5113977) · CC0 1.0
- [2]Management of ME/CFS · CC BY-SA 4.0
- [3]Myalgic encephalomyelitis/chronic fatigue syndrome · CC BY-SA 4.0
- [4]Chronic Lyme disease · CC BY-SA 4.0
- [5]Idiopathic chronic fatigue · CC BY-SA 4.0